SJUTS DUSTIN S (Chief Commercial Officer) received a stock award from REVANCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/5/2023ACC: 0001479290-23-000082
Officer· Chief Commercial Officer
Since Dec 2019
+1K
Net shares
Net buyer
$15.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
$15.61
Trade value
$15.61K
% of position
0.7%
6/30/2023
147.35K→148.35K
Total
Net shares
+1K
Net value
$15.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2023 | A · Award | +1K | $15.61 | $15.61K | 0.7% | 147.35K | 148.35K |
| Total | +1K | $15.61K | ||||||
Derivative Transactions0
No derivative transactions reported